Consumers are not lovin’ it: McDonald’s has its worst quarter since 2020
McDonald’s reported its worst quarterly sales for the United States since the height of the pandemic in 2020, the latest...
Big Tech, Big Data, Big Moves: Why This Week Could Be a Market Game-Changer
Speaking overall, the stock market hasn’t changed course after last week’s bounce; the upside momentum is still here, albeit acting...
Ready To Level Up Your Options Trading?
Grow your trading account using proven options strategies, right from your StockCharts ChartLists, with the help of this powerful educational...
Element79 Announces Extension to Proposed Spin Out and Merger
(TheNewswire) VANCOUVER, BC TheNewswire – May 1, 2025 Element79 Gold Corp. (CSE: ELEM) (OTC: ELMGF) (FSE: 7YS) (‘Element79’, or the...
Rio Silver completes Definitive Agreement for the sale of Ninobamba, announces planned restructuring
Rio Silver Inc. (‘Rio Silver’ or the ‘Company’) (TSX.V: RYO) (OTC: RYOOF), announces that it has completed a definitive agreement...
LaFleur Minerals Begins Permitting Process for a Bulk Sample from the Swanson Deposit to be Processed at its Beacon Gold Mill
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’) is pleased to announce that it...
Charbone Hydrogene signe une entente de conditions pour une facilite de credit de construction de 50 millions USD
(TheNewswire) Brossard (Québec) TheNewswire – le 1 er mai 2025 – CORPORATION CHARBONE HYDROGÈNE (TSXV: CH OTCQB: CHHYF, FSE: K47...
CHARBONE Hydrogen Signed a USD 50 Million Construction Capital Facility Term Sheet
(TheNewswire) Brossard, Quebec TheNewswire – May 1, 2025 Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the ‘Company’ or...
IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing
International Business Machines Corporation on Monday announced it will invest $150 billion in the U.S. over the next five years, including...
Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D
Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in...
